<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03474627</url>
  </required_header>
  <id_info>
    <org_study_id>H1452514461215</org_study_id>
    <nct_id>NCT03474627</nct_id>
  </id_info>
  <brief_title>PLGA-coated Biphasic Calcium Phosphate in Sinus Lift</brief_title>
  <official_title>Sinus Floor Elevation Using Particulate and in Situ Hardening Biphasic Calcium Phosphate Bone Graft Substitutes: A Prospective Histological and Radiological Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Granada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Valencia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad de Granada</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to investigate the radiological and histomorphometric results of the use of
      PLGA-coated biphasic calcium phosphate granules in sinus floor elevation, to analyze the
      underlying molecular processes by immunohistochemical staining, and to evaluate the handling
      of the biomaterial and the in situ hardening properties.

      A randomized clinical study is designed to include patients in need of two-stage sinus floor
      elevation. Patients are assigned to receive either PLGA-coated biphasic calcium phosphate
      particles (group I) or the equivalent but non-coated particles (group II). CBCT scans are
      performed before and 6 months after the procedure to assess the bone height gain. At the time
      of implant placement, bone core biopsies are obtained at the site of implant placement.
      Histological sections are subjected to histomorphometric and immunohistochemical evaluation
      of differentiation markers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2012</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sinus floor height change</measure>
    <time_frame>6 months</time_frame>
    <description>CBCT scans are performed before the sinus floor elevation and 6 months later before implant placement to measure vertical bone height from the crestal bone to the floor of the maxillary sinus.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Area of new mineralized tissue</measure>
    <time_frame>6 months</time_frame>
    <description>Histomorphometric quantification of new mineralized tissue in a bone biopsy collected 6 months after the grafting procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area of non-mineralized tissue</measure>
    <time_frame>6 months</time_frame>
    <description>Histomorphometric quantification of non-mineralized tissue in a bone biopsy collected 6 months after the grafting procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area of remaining graft particles</measure>
    <time_frame>6 months</time_frame>
    <description>Histomorphometric quantification of remaining graft particles in a bone biopsy collected 6 months after the grafting procedure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Sinus Floor Augmentation</condition>
  <arm_group>
    <arm_group_label>Non-coated HA/TCP particles</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Biphasic hydroxyapatite and beta-tricalcium phosphate bone graft</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PLGA-coated HA/TCP particles</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Biphasic hydroxyapatite and beta-tricalcium phosphate bone graft with PLGA coating</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-coated HA/TCP particles</intervention_name>
    <description>Maxillary sinus floor elevation and bone grafting with the use of biphasic hydroxyapatite and beta-tricalcium phosphate bone graft</description>
    <arm_group_label>Non-coated HA/TCP particles</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PLGA-coated HA/TCP particles</intervention_name>
    <description>Maxillary sinus floor elevation and bone grafting with the use of biphasic hydroxyapatite and beta-tricalcium phosphate bone graft with PLGA coating</description>
    <arm_group_label>PLGA-coated HA/TCP particles</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Partially edentulous patients.

          -  Kennedy class I or II in the upper jaw, from first premolar to second molar.

          -  Less than 5 mm of residual crestal bone.

          -  Need for the replacement of teeth with dental implants.

        Exclusion Criteria:

          -  Sinus pathology (sinusitis, mucocele, cysts).

          -  Smokers.

          -  Previous long-term (&gt;3 months) use of drugs known to affect bone metabolism, such as
             bisphosphonates.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio J Flichy-Fernandez, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Valencia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Granada</name>
      <address>
        <city>Granada</city>
        <zip>18071</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universidad de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Galindo-Moreno P, Hernández-Cortés P, Mesa F, Carranza N, Juodzbalys G, Aguilar M, O'Valle F. Slow resorption of anorganic bovine bone by osteoclasts in maxillary sinus augmentation. Clin Implant Dent Relat Res. 2013 Dec;15(6):858-66. doi: 10.1111/j.1708-8208.2012.00445.x. Epub 2012 Feb 29.</citation>
    <PMID>22376122</PMID>
  </reference>
  <reference>
    <citation>Ortega-Oller I, Del Castillo-Santaella T, Padial-Molina M, Galindo-Moreno P, Jódar-Reyes AB, Peula-García JM. Dual delivery nanosystem for biomolecules. Formulation, characterization, and in vitro release. Colloids Surf B Biointerfaces. 2017 Nov 1;159:586-595. doi: 10.1016/j.colsurfb.2017.08.027. Epub 2017 Aug 24.</citation>
    <PMID>28854415</PMID>
  </reference>
  <reference>
    <citation>Galindo-Moreno P, Avila G, Fernández-Barbero JE, Aguilar M, Sánchez-Fernández E, Cutando A, Wang HL. Evaluation of sinus floor elevation using a composite bone graft mixture. Clin Oral Implants Res. 2007 Jun;18(3):376-82. Epub 2007 Mar 12.</citation>
    <PMID>17355356</PMID>
  </reference>
  <reference>
    <citation>Galindo-Moreno P, de Buitrago JG, Padial-Molina M, Fernández-Barbero JE, Ata-Ali J, O Valle F. Histopathological comparison of healing after maxillary sinus augmentation using xenograft mixed with autogenous bone versus allograft mixed with autogenous bone. Clin Oral Implants Res. 2018 Feb;29(2):192-201. doi: 10.1111/clr.13098. Epub 2017 Oct 26.</citation>
    <PMID>29071736</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2018</study_first_submitted>
  <study_first_submitted_qc>March 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2018</study_first_posted>
  <last_update_submitted>March 15, 2018</last_update_submitted>
  <last_update_submitted_qc>March 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Granada</investigator_affiliation>
    <investigator_full_name>Pablo Galindo-Moreno</investigator_full_name>
    <investigator_title>Full Professor of Oral Surgery and Implant Dentistry</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

